Physician profile
Todd John Endicott
NPI 1831393644
$4,293.88
in general payments reported to CMS, 2019-2025
15 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.40 · 2021: $31.19 · 2022: $319 · 2023: $1,989 · 2024: $706 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,393 · Travel and Lodging: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,392.59 |
| Travel and Lodging | $1,531.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,160.83 | 2021-2025 | Lensx, Clareon, Ngenuity |
| Abbvie INC. | $296.08 | 2023-2025 | |
| Rxsight INC | $227.32 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $196.10 | 2023-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Tarsus Pharmaceuticals, INC. | $66.76 | 2024 | Xdemvy |
| Ocular Therapeutix, INC. | $66.04 | 2023-2025 | Dextenza |
| Dompe US, INC. | $54.27 | 2025 | Oxervate |
| Sight Sciences, INC. | $52.00 | 2024-2025 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $44.10 | 2024-2025 | Miebo, Xiidra |
| Rayner Intraocular Lenses Limited | $39.60 | 2025 | Omidria |
| Johnson & Johnson Surgical Vision, INC. | $26.04 | 2024 | Tecnis Simplicity |
| Harrow Eye, LLC | $20.73 | 2024 | Vevye |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $18.80 | 2023 | Tyrvaya |
| New World Medical,INC. | $5.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Endicott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.